Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission.

Post date May 11, 2022 — 20:31 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Don't be afraid of fluctuations! The April list of the 2nd "Jinhua Cai Cup" Private Equity Competition of West China Securities was released

May 20, 2022 — 18:00

Junda Co., Ltd. (002865): Completed industrial and commercial change registration CFi.CN Zhongcai Network

May 20, 2022 — 17:55

Heyuan Gas (002971): Completed industrial and commercial change registration and renewed business license CFi.CN Zhongcai Network

May 20, 2022 — 17:45

Desay SV (002920): Shareholders holding more than 5% of the shares participate in the progress of the refinancing and lending business and terminate the lending business in advance- CFi.CN Zhongcai Network

May 20, 2022 — 17:45

Ang Likang (002940): Pledge of part of the shares of the company's controlling shareholder- CFi.CN Zhongcai Network

May 20, 2022 — 17:40

Myopia is guilty, is it justified to take off the mirror? Aier Ophthalmology was fined for violating the Advertising Law. Netizens: Please treat yourself first! -Finance-financial world

May 20, 2022 — 17:39

Hongxun Technology (603015): Part of the shares of the controlling shareholder acting in concert release the pledge- CFi.CN Zhongcai Network

May 20, 2022 — 16:52

Gold Stone Resources (603505): Gold Stone Resources Group Co., Ltd. on the pledge of some shares of the controlling shareholder- CFi.CN Zhongcai Network

May 20, 2022 — 16:50

The securities sector rose 1.63%, Caida Securities rose 10.03% to top the list – yqqlm

May 20, 2022 — 16:50

Home » News » Aier Ophthalmology: The application for non-public offering of shares has been reviewed and approved by the China Securities Regulatory Commission.